Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: A randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer

Edith A. Perez, Sara A. Hurvitz, Lukas C. Amler, Kirsten E. Mundt, Vivian Ng, Ellie Guardino, Luca Gianni

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: A randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences